Lactose Intolerance Clinical Trial
Official title:
Evaluation of GIMate Handheld Hydrogen Breath Monitor for Diagnosis of Lactose Malabsorption
The goal of this study is to assess the performance of the Vivante Health GIMate Breathalyzer device in diagnosing lactose malabsorption.
Lactose malabsorption is a common condition due to lactase deficiency which results in gastrointestinal symptoms for many which is termed lactose intolerance. Lactase is an enzyme occurring in the intestinal mucosa that hydrolyzes lactose into its constituent parts, galactose and glucose. The enzyme is normally present in neonates, however, for a majority of individuals in the world there is an inherited and irreversible reduction in enzyme activity as individuals age. Secondary lactose malabsorption can also occur when there is injury to the intestinal mucosa from a reversible condition such as infection. The mechanism of hydrogen detection is based on undigested lactose in the colon being fermented by bacteria resulting in the production of hydrogen which is then partially absorbed into the bloodstream and ultimately exhaled by the lungs via the pulmonary circulation and gas exchange. Direct lactase activity can also be measured on tissue obtained through jejunal biopsy via endoscopy. This approach, however, is more invasive, costly, and potentially less reliable given issues relating to sampling bias Current clinical hydrogen breath tests for diagnosis of lactose malabsorption are bulky and expensive for clinical providers to use and obtain. As a result, Vivante Health is testing how effective the GIMate device is in diagnosing lactose malabsorption as an alternative option. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05100719 -
The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION)
|
N/A | |
Completed |
NCT02518295 -
β-galactosidase Producing Probiotic Strains to Improve Lactose Digestion
|
N/A | |
Completed |
NCT00599859 -
Effects of Lactose on Fecal Microflora
|
N/A | |
Completed |
NCT02636413 -
Evaluation of LacTEST for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance
|
Phase 4 | |
Completed |
NCT02406469 -
Effects Comparison of A1 and A2 Milk on Gastrointestinal Physiology, Symptoms and Cognitive Behavior
|
Phase 4 | |
Terminated |
NCT00247806 -
Prevalence of Lactose Intolerance Following Stem Cell Transplantation
|
Phase 1 | |
Completed |
NCT03814668 -
Effect of Probiotic Supplementation on Lactose Maldigestion Induced by Lactose Solution
|
N/A | |
Completed |
NCT03860051 -
Association Between Lactase Deficiency, and the Small Intestinal Microbiome in Adults.
|
||
Not yet recruiting |
NCT06107088 -
Effect of a Combination of Lactase and L. Salivarius DSM 34078 in Individuals With Lactose Intolerance
|
N/A | |
Completed |
NCT02703987 -
HYBRID: Hydrogen Breath Test in Lactose Digestion
|
N/A | |
Completed |
NCT00395954 -
Amount of Lactose Causing Symptoms in Lactose Intolerant People
|
Phase 0 | |
Completed |
NCT01593800 -
The Effect of Probiotics on Lactose Intolerance
|
N/A | |
Completed |
NCT04164394 -
Effect of I31 Probiotic on Lactose Intolerance
|
N/A | |
Recruiting |
NCT05668468 -
A Bifido Bacteria to Improve Lactose Digestion and Tolerance
|
N/A | |
Completed |
NCT03563846 -
Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects
|
Phase 1 | |
Recruiting |
NCT02085889 -
Fructose and Lactose Intolerance and Malabsorption in Functional Gastrointestinal Disorders
|
||
Completed |
NCT03597516 -
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
|
Phase 3 | |
Not yet recruiting |
NCT03563859 -
Evaluation of Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
|
Phase 3 | |
Completed |
NCT02171403 -
Comparison of the Colonic Metabolism in Patients With Lactose Intolerance and Healthy Controls
|
N/A | |
Completed |
NCT01145586 -
A Non-inferiority, Multicenter and Randomized, Multiple-Dose Study About a Treatment to Hypolactasia
|
Phase 3 |